Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; 6 of the 29 sources its claims cite were checked for support.
Abstract
Background: Poststroke dysarthria, a common speech impairment, affects up to half of all stroke survivors, often reducing their ability to communicate, and adversely affecting their quality of life. Although conventional speech therapy for poststroke dysarthria is effective, access is often limited by time and geographical constraints. Here, digital speech therapy may serve as a remotely deliverable alternative for selected patients. However, few trials have assessed its efficacy, safety, and usability. Objective: This study aimed to evaluate whether a smartphone-based speech therapy app is noninferior to conventional workbook-based therapy in improving speech intelligibility among individuals with poststroke dysarthria. Methods: This single-blind, randomized controlled, noninferiority trial was performed at 3 hospitals in South Korea. Adults (≥19 y) with poststroke dysarthria who were cognitively intact, without aphasia, and able to use a smartphone were eligible. Participants were enrolled between July 20, 2023, and April 15, 2024. Participants were randomly assigned (1:1), stratified by stroke phase, using a block randomization method, to receive either a smartphone-based digital therapy app or a conventional workbook-based therapy for 4 weeks. The primary outcome was speech intelligibility (0-100 perceptual rating) after the intervention. Primary analysis was intention-to-treat using analysis of covariance. A noninferiority margin of 19 points was pre-defined. Results: A total of 73 participants were enrolled (median age 62.00 years). Among them, 38 were assigned to the digital speech therapy group and 35 to the control group. Intelligibility scores improved from 80.48 (SD 18.92) to 92.08 (SD 12.38) in the intervention group, and from 80.94 (SD 16.74) to 88.11 (SD 18.06) in the control group. The adjusted between-group difference was 4.49 (95% CI 0.61-8.37), and the lower bound of the 95% CI was above the prespecified noninferiority margin (-19), which supported noninferiority. No significant between-group differences were observed in the secondary outcomes related to speech function or psychological status. The system usability score was 89.6, and adherence in the digital speech therapy group was 64.6% based on app logs, with no treatment-related adverse events. Conclusions: Digital speech therapy was noninferior to conventional workbook-based therapy in improving speech intelligibility and was feasible across acute to early subacute and chronic stroke phases in cognitively intact stroke survivors with predominantly mild-to-moderate dysarthria. However, feasibility and efficacy in older stroke survivors with cognitive deficits or co-occurring aphasia, or in those unable to use smartphones, remain to be established.
Overview
CoChat Summary
TL;DR
In a multicenter randomized noninferiority trial, a smartphone-based digital speech therapy app was noninferior to conventional workbook-based therapy for improving speech intelligibility in poststroke dysarthria. The adjusted between-group difference was 4.49 points (95% CI 0.61-8.37), with the lower CI bound above the prespecified –19-point margin.
Key findings
- Speech intelligibility improved from 80.48 (SD 18.92) to 92.08 (SD 12.38) in the digital therapy group and from 80.94 (SD 16.74) to 88.11 (SD 18.06) in the control group; the adjusted mean difference was 4.49 (95% CI 0.61-8.37), supporting noninferiority.
- No significant between-group differences were found for secondary speech function or psychological outcomes, including MPT (0.82, 95% CI –1.26 to 2.91; P=.43), PCC (0.14, 95% CI –1.82 to 2.10; P=.88), PHQ-9 (–1.02, 95% CI –3.16 to 1.13; P=.35), and QoL-Dys total (–3.04, 95% CI –14.72 to 8.65; P=.61).
- Usability in the digital group was high (mean SUS 89.57, SD 10.70), adherence was 64.6% by app logs, and no treatment-related adverse events were reported.
- Per-protocol analysis (n=46) showed an adjusted difference of 3.57 (95% CI –1.79 to 8.92), also above the noninferiority margin.
Methods
- Multicenter, prospective, evaluator-blinded, randomized controlled noninferiority trial at 3 hospitals in South Korea; 73 adults with poststroke dysarthria were randomized 1:1 to smartphone-based digital therapy (n=38) or conventional workbook-based therapy (n=35), stratified by stroke phase.
- Eligible participants were ≥19 years, cognitively intact (MMSE ≥26), without aphasia, and able to use a smartphone; both groups were prescribed 60 minutes/day, 5 days/week for 4 weeks.
- Primary outcome was speech intelligibility (0-100 perceptual rating) after intervention, assessed from the Gaeul Passage by 3 blinded SLPs; primary analysis was intention-to-treat ANCOVA adjusting for baseline intelligibility and age, with a prespecified noninferiority margin of –19 points.
Limitations
- The paper states the sample was slightly below the planned size (73 vs 76), may be underpowered for secondary outcomes or subgroup effects, and lacked follow-up beyond the 4-week intervention.
- The paper states generalizability is limited to cognitively intact, nonaphasic, smartphone-capable Korean speakers with predominantly mild-to-moderate dysarthria; comparator workbook therapy may not fully capture face-to-face SLP feedback, control adherence was self-reported, personalization differed between arms, and usability was assessed only in the intervention group.
- The paper also notes high baseline intelligibility (median 89.00%) and a task-based passage-reading outcome may have limited measurement sensitivity and complicate interpretation of the 19-point noninferiority margin; the text makes evident an age imbalance favoring the younger intervention group.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
6 Valid · 0 Not valid · 18 Not checked · 125 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Previous small-sample studies have suggested potential benefits of digital speech therapy for individuals with poststroke dysarthria in the chronic phase [17-19].”
§ Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial > Introduction
What the sources say
- Partly supportedcites [17] Mitchell, Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury, Cochrane Database Syst Rev sourceExperimental — accuracy not yet measured
The Main results section reports small trials, including two that recruited people with chronic dysarthria. The Characteristics of ongoing studies section describes an online poststroke dysarthria therapy, ReaDySpeech, but reports a planned feasibility trial and proof of deliverability—not evidence of therapeutic benefit. The review therefore does not support the claim that previous small studies suggested benefits of digital therapy specifically in the chronic poststroke phase. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [18] Mahler, Intensive treatment of dysarthria secondary to stroke, Clin Linguist Phon source
- Not checked — no full text of the sourcecites [19] Park, Be clear: a new intensive speech treatment for adults with nonprogressive dysarthria, Am J Speech Lang Pathol source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“which aligns with the lower bound of the cited minimal clinically important difference range [41]”
§ Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial > Discussion > Principal Findings
What the sources say
- Supportedcites [41] Stipancic, Progress toward estimating the minimal clinically important difference of intelligibility: a crowdsourced perceptual experiment, J Speech Lang Hear Res source
The section “Valid MCIDs of Sentence Intelligibility Were Calculated” (page not available in our copy) gives 7% as the threshold for a small clinically meaningful difference and 15% for a large one. This supports the cited lower bound. The workbook-based control arm’s mean is the citing authors’ result, not a result attributed to this source. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the intervention group, participants completed a mean of 64.6% of the prescribed sessions according to objective application logs.”
§ Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial > Results > Evaluation Outcomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No significant differences were observed in any of the 4 QoL-Dys subdomains.”
§ Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial > Results > Evaluation Outcomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The treatment-by-phase interaction test showed no evidence of differential effects by stroke phase.”
§ Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial > Results > Evaluation Outcomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
64 more claims
Create a free account to see all 149 claims and every source verdict.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 53
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial > Results > Evaluation Outcomes
“| Overall | | | 4.49 (0.61 to 8.37) | 5.32 (1, 67) | .02 | 0.07 |”
§ Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial > Methods > Statistical Analysis
“The primary analysis was conducted on the intention-to-treat (ITT) population, which included all randomized participants. To handle missing postintervention data, the last observation carried forward method was applied (baseline carried forward).”
Citations
Cites
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802 · cited 1×
“Psychological well-being was assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item self-report scale for depressive symptoms [36], with lower scores indicating reduced symptom severity.”
SUS: A 'Quick and Dirty' Usability Scale
(1996) · Usability Evaluation In Industry · doi:10.1201/9781498710411-35 · Cited by 8,989
World Stroke Organization (WSO): Global Stroke Fact Sheet 2022
Feigin, V. L., Brainin, M., Norrving, B., Martins, S., Sacco, R. L., Hacke, W., Fisher, M., Pandian, J., & Lindsay, P. (2022) · International Journal of Stroke · doi:10.1177/17474930211065917 · Cited by 2,979 · cited 1×
“Stroke is a leading cause of death and long-term disability worldwide [1].”
Differential diagnostic patterns of dysarthria
Darley, F. L., Aronson, A. E., & Brown, J. R. (1969) · Journal of Speech and Hearing Research · doi:10.1044/jshr.1202.246 · Cited by 1,323 · cited 1×
“Additionally, approximately 35% of patients with poststroke dysarthria continue to experience dysarthria after 6 months [2-5].”
Bernhardt, J., Hayward, K. S., Kwakkel, G., Ward, N. S., Wolf, S. L., Borschmann, K., Krakauer, J. W., Boyd, L. A., Carmichael, S. T., Corbett, D., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493017711816 · Cited by 1,189 · cited 1×
“The chronic phase was defined as 6 months or more after stroke onset [25].”
The Role of Telehealth in Reducing the Mental Health Burden from COVID-19
Zhou, X., Snoswell, C. L., Harding, L. E., Bambling, M., Edirippulige, S., Bai, X., & Smith, A. C. (2020) · Telemedicine and e-Health · doi:10.1089/tmj.2020.0068 · Cited by 1,159 · cited 1×
“They also help maintain continuity of care after hospital discharge and encourage patients to practice independently [14-16].”
Blinding in randomised trials: hiding who got what
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07816-9 · Cited by 952 · cited 1×
“This approach ensured objective evaluation of the primary outcomes despite the open-label design of the trial [27].”
Intensity of Aphasia Therapy, Impact on Recovery
Bhogal, S. K., Teasell, R., & Speechley, M. (2003) · Stroke · doi:10.1161/01.str.0000062343.64383.d0 · Cited by 719 · cited 1×
“This is of particular interest given the widely cited hypothesis that the early poststroke phase represents a sensitive period of heightened neuroplasticity and responsiveness to therapy [49,50].”
Telemedicine, Telehealth, and Mobile Health Applications That Work: Opportunities and Barriers
Weinstein, R. S., Lopez, A. M., Joseph, B. A., Erps, K. A., Holcomb, M., Barker, G. P., & Krupinski, E. A. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.09.032 · Cited by 594 · cited 1×
“These findings echo earlier reports indicating that stroke survivors appreciate the autonomy and flexibility offered by well-designed mobile therapy tools [14,15,55].”
Research works printed but not linked: 5
- Duffy JR . Motor Speech Disorders: Substrates, Differential Diagnosis, and Management. 4th ed. Elsevier; 2020. ISBN: 9780323530545
- KIM, Journal of Korean Neuropsychiatric Association, 42, 124
- Isaacson, Am Fam Physician, 68, 1125
- Kim HH . Perceptual, acoustical, and physiological tools in ataxic dysarthria management: a case report. Presented at: Proceedings of the 2nd Conference of the Korean Society of Phonetic Sciences and Speech Technology; 9-22; Seoul, South Korea. 1996.URL: https://koreascience.kr/article/CFKO199613842057217.page [Accessed 08-05-2026]
- King, J Med Speech Lang Pathol, 20, 1
Metadata
- Authors
- Kim, Y., Kim, M., Kim, S., Kim, J., Shin, J.-H., Chang, Y., Na, J. Y., Kim, J., & Song, T.-J.
- Affiliations
- Yonsei University (KR)
- National Rehabilitation Center (KR)
- Ewha Womans University (KR)
- Korea Nazarene University (KR)
- Corresponding author
- Song, Tae-Jin
- ORCID
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2026-05-18
- Volume
- 28
- Pages
- e81938-e81938
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC13182877
- OpenAlex
- W7161589653
- Cited by
- 0
- References
- 48
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation (BK21 FOUR)
- Korea Health Industry Development Institute (RS-2023-00262087, NRF-5199990614253, HI22C073600)
- National Research Foundation of Korea (NRF‐5199990614253, HI22C073600, 5199990614253, 2022-0-00621)
- Ministry of Education, India
- Ministry of Science and ICT, South Korea (2022-0-00621, BK21 FOUR, RS-2023)
- Institute for Information and Communications Technology Promotion (2022-0-00621, 2022-)
- Topics
- Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Health Sciences › Health Professions › Speech and Hearing › Dysphagia Assessment and Management
- Keywords
- speech intelligibility, non-inferiority, stroke rehabilitation, system usability, medication adherence, stroke survivors, quality of life, psychological well-being, speech function
- MeSH terms
- Smartphone, Aged, Dysarthria, Female, Humans, Male, Middle Aged, Speech Therapy, Single-Blind Method, Treatment Outcome, Stroke, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.